8-K

Company

Foghorn Therapeutics Inc.

Filed

September 1, 2021

Period of Report

August 30, 2021

Accession Number

0001628280-21-017921

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →